Trade Ideas April 26, 2026 08:23 AM

Intel's Turnaround: Momentum, Risks, and a Concrete Trade

After a dramatic rebound, Intel looks like a workable swing trade — but execution and valuation questions remain.

By Avery Klein INTC
Intel's Turnaround: Momentum, Risks, and a Concrete Trade
INTC

Intel has gone from near-distress to market darling in a few quarters. Earnings momentum in data center and AI, a recovering foundry narrative, and a dramatic multiple re-rating have created a clear trade setup: buy a disciplined pullback and ride the near-term re-pricing while watching execution closely. This note lays out the thesis, supporting numbers, catalysts, and an explicit entry, stop and target for a mid-term trade (45 trading days).

Key Points

  • Intel’s stock has re-rated sharply after recent quarter beats and DCAI strength; current price reflects improving execution but also high expectations.
  • Valuation is elevated (EV/EBITDA ~38x and market cap ~ $418B) and requires continued margin recovery and positive free cash flow to sustain.
  • Concrete trade: buy $80.00, stop $68.00, target $110.00, mid term (45 trading days).
  • Catalysts include further DCAI wins, IFS milestones, and successive beats with raised guidance; watch for FCF stabilization and capex clarity.

Hook and thesis

Intel's stock has run hard — it closed the prior session around $66.78 and is now trading above $82 — but the move is not hype without footing. Recent quarterly results showed a meaningful improvement in its Data Center and AI division, the company is latching onto real AI-driven CPU demand, and the market is re-pricing the company away from its low in 2025 toward a much higher multiple. That re-rating creates a practical, actionable swing trade: buy on confirmed support or light pullbacks and take profits on a measured multi-week run.

My thesis is straightforward: the market is beginning to reward Intel's execution on two fronts - stabilizing client demand via pricing and product cycles, and expanding DCAI (Data Center & AI) sales that are benefiting from agentic AI workloads. That combination can drive near-term revenue and margin upside while the narrative around Intel Foundry Services remains binary. This is a trade on momentum and proof-of-execution, not a full conviction buy for every investor.

What Intel does and why the market should care

Intel designs, manufactures and sells a range of computing products across Client Computing Group (notebooks/desktops), Data Center & AI (server CPUs and high-performance silicon), and Intel Foundry Services (IFS) which provides contract manufacturing. The DCAI segment is the strategic pivot: cloud and enterprise customers are adding CPU density to support AI inference, specialty accelerators, and tightly-coupled CPU/GPU workflows. The market cares because if Intel executes commercially on DCAI and stabilizes its foundry roadmap, it can convert its large install base and manufacturing capacity into durable revenue and margin expansion.

Key numbers backing the setup

Metric Value
Current Price $82.73
52-week range $18.97 - $85.22
Market Cap $417.8B
Enterprise Value $447.2B
EV / EBITDA 38.3x
Price / Book ~3.63x
Free Cash Flow (latest) -$4.95B
Trailing EPS (reported close to Q1) Mixed - recent press cited an adjusted EPS beat of $0.29 vs $0.01 expected

Those numbers paint a mixed picture. Valuation multiples like EV/EBITDA ~38x and price-to-sales pushing into higher territory reflect a market that is assuming material margin recovery and growth. At the same time, cash flow is still negative on a recent basis. The practical read: investors are paying for improved execution, and Intel needs to deliver more than just beat-and-raise headlines to justify further multiple expansion.

Technical and market positioning

Liquidity is high: daily volume has jumped to an average north of ~110M shares, and today's volume topped ~281M. Short interest remains meaningful (recent reads well over 100M shares) but days-to-cover are low, making dramatic squeezes less likely. Momentum indicators are hot: the RSI sits in the low 80s and MACD is bullish. That means the stock can extend but also that an orderly pullback would be welcome as a lower-risk entry.

Valuation framing

At roughly $418B market cap and an EV near $447B, the market is pricing Intel more like a growth/recovery story than the deeply discounted factory play it was in mid-2025. EV/EBITDA near 38x is elevated versus historical Intel norms and requires either sustained margin expansion, accelerating revenue growth, or both. A more conservative fair-value case assumes partial success: if data center revenue continues growing from the recent reported ~$5.1B quarterly run-rate and margins normalize, the multiple could be rationalized. If Intel fails to convert IFS into profitable scale or free cash flow remains negative, downside is still material despite the run-up.

Catalysts to watch (2-5)

  • Follow-through in Data Center & AI revenue: additional large cloud wins or share gains with partners like Google or Tesla would validate the recent beat and sustain momentum.
  • IFS milestones: evidence of profitable foundry ramp or meaningful third-party design wins would reduce execution risk and support further re-rating.
  • Subsequent quarterly guidance: successive beats and raised guidance would make the current multiples look more reasonable.
  • Macro chip cycle: tightening supply in key nodes or sustained AI capex growth that boosts pricing and utilization across fabs.

Concrete trade plan

This is a mid-term swing trade designed to capture the next phase of re-pricing while protecting capital if execution stalls.

  • Entry Price: $80.00 — buy on either a small intraday pullback to $80 or on any consolidation that holds above $78 with confirmed volume support.
  • Stop Loss: $68.00 — a break under $68 signals loss of the recent momentum run and invalidates the near-term recovery thesis.
  • Target Price: $110.00 — primary target for this swing, represents a further multiple expansion and an earnings/margin realization scenario. Consider partial profit-taking at $95 to lock gains.
  • Horizon: mid term (45 trading days) — I expect the market to price further clarity into results, partner announcements, or guidance over the next ~2 months; this is not a buy-and-forget position.

Position sizing and management: Limit exposure to a size that you are comfortable with given execution risk — I would recommend no more than 2-4% of portfolio capital on a single swing trade here. Trim into strength and tighten the stop after a meaningful move higher (e.g., move stop to breakeven once price > $95).

Risks and counterarguments

Any trade on Intel today is a bet that the company can continue to execute on multiple fronts. Below are the primary risks to this trade and a counterargument to my thesis.

  • Foundry execution risk - IFS remains a capital-intensive, execution-heavy initiative. If manufacturing ramps falter or yields disappoint, capital expenditure and margin pressure could reappear and the multiple would compress.
  • Free cash flow and profitability - the latest reported free cash flow was negative (~-$4.95B). Continued negative FCF undermines valuation and forces either higher leverage or additional equity issuance.
  • Competitive dynamics - rivals (internal custom silicon efforts at hyperscalers, AMD, Nvidia in adjacent workloads) can erode pricing power and growth prospects for Intel's data center silicon.
  • Valuation vulnerability - multiples are rich relative to Intel's recent history; a market rotation out of growth or any macro shock could produce a sharp pullback, especially with RSI elevated.
  • Short-term momentum reversal - technical indicators show overbought territory. If momentum stalls, expect a quick retracement back toward prior moving averages.

Counterargument: One can reasonably argue that Intel's run is overdone and priced for near-perfect execution. EV/EBITDA near 38x and a market cap north of $400B already discounts a sizable recovery. If Q2 guidance softens or if a major hyperscaler chooses alternative silicon at scale, the stock has material downside relative to current levels. That counterargument is why I advocate a disciplined stop at $68 and conservative sizing.

What would change my mind

I will become more constructive and consider a larger position if Intel delivers a sequence of quarterly beats with raised guidance, sustained positive free cash flow, and clear evidence that IFS is moving from investment mode to revenue contribution without incremental margin dilution. Conversely, failure to hold $68 or any public sign of a major design/partner loss would push me to a bearish stance.

Conclusion and stance

Actionable stance: Tactical long via a mid-term swing. This is a measured, event-driven trade rather than a full conviction buy. The company has shown tangible signs of recovery in DCAI and the market is rewarding that progress — but the valuation is not cheap and execution risk is real. Buy at $80 with a $68 stop and a primary target of $110 over the next 45 trading days, scale out into strength, and treat any sign of foundry or cash flow deterioration as a signal to reduce exposure.

Key dates and items to watch

  • Follow-up quarterly report and guidance updates after the recent Q1 momentum reported on 04/24/2026.
  • Public announcements from major cloud customers or foundry design wins.
  • Monthly/quarterly cash flow and capex cadence showing stabilization into positive free cash flow.

Trade idea summary: Buy at $80.00, stop $68.00, target $110.00, mid term (45 trading days). Keep size conservative and tighten stops on strength.

Risks

  • Foundry (IFS) execution may fall short, leading to capital overruns, yield problems, and renewed margin pressure.
  • Free cash flow remains negative; persistent negative FCF would undermine valuation and could force financing that dilutes shareholders.
  • Competitive displacement from hyperscaler custom silicon, AMD, and accelerators reducing CPU content per server.
  • Technical momentum is stretched (RSI ~82); a short-term reversal could produce a rapid pullback back to prior averages.

More from Trade Ideas

Multiple Target Hit — Upgrading Nasdaq (NDAQ) to Buy as New Catalysts Kick In Apr 26, 2026 Textron After the Pullback: A Value-Laced Entry Despite Near-Term Headwinds Apr 26, 2026 Expedia: Buy the Recovery But Size Your Position - Valuation Supports a Measured Rally Apr 26, 2026 Buy MercadoLibre: 25% EPS Growth Could Compound to 3x Equity by 2031 Apr 26, 2026 Akzo Nobel ADR: Cheap, Cash-Generating Coatings Play with ~27% Upside to $26 Apr 26, 2026